The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Trial: anti-PD1 and anti-KIR combined

Alexandra
Alexandra CSN Member Posts: 1,308
in Ovarian Cancer #1

IS ANYONE PARTICIPATING IN THIS TRIAL?

This trial sounds very promising. It combines two experimental drugs, the much-sought-after PD-1 drug BMS-936558 (nivolumab) and an anti-KIR drug BMS-986015. This trial is available to qualified patients with colorectal cancer, kidney cancer, melanoma, NSCLC (non-small cell lung cancer), and ovarian cancer. The trial is underway in Baltimore, Chicago, and New York.

Note: This trial is not yet recruiting in Boston or Portland.

http://clinicaltrials.gov/show/NCT01714739

 

Like Care

Comments

  • DaveMcF
    DaveMcF CSN Member Posts: 1
    #2
    Any Luck

    Curious if anyone has particiapted in this trial.  I am just starting my search for a promising trial that includes Anti-PD1.

    Like Care

Discussion Boards